Journal article
Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis
R Immonen, G Smith, RD Brady, D Wright, L Johnston, NG Harris, E Manninen, R Salo, C Branch, D Duncan, R Cabeen, XE Ndode-Ekane, CS Gomez, PM Casillas-Espinosa, I Ali, SR Shultz, P Andrade, N Puhakka, RJ Staba, TJ O'Brien Show all
Epilepsy Research | ELSEVIER SCIENCE BV | Published : 2019
Abstract
Preclinical imaging studies of posttraumatic epileptogenesis (PTE) have largely been proof-of-concept studies with limited animal numbers, and thus lack the statistical power for biomarker discovery. Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a pioneering multicenter trial investigating preclinical imaging biomarkers of PTE. EpiBios4Rx faced the issue of harmonizing the magnetic resonance imaging (MRI) procedures and imaging data metrics prior to its execution. We present here the harmonization process between three preclinical MRI facilities at the University of Eastern Finland (UEF), the University of Melbourne (Melbourne), and the University of California,..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This research was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Center without Walls of the National Institutes of Health (NIH) under Award Number U54NS100064 (EpiBioS4Rx).